{"id":1783,"date":"2021-04-13T10:00:29","date_gmt":"2021-04-13T14:00:29","guid":{"rendered":"http:\/\/carolinaurologicresearchcenter.com\/?p=1783"},"modified":"2021-05-20T10:17:33","modified_gmt":"2021-05-20T14:17:33","slug":"efficacy-of-enzalutamide-plus-androgen-deprivation-therapy-in-metastatic-hormone-sensitive-prostate-cancer-by-pattern-of-metastatic-spread-arches-post-hoc-analyses","status":"publish","type":"post","link":"https:\/\/carolinaurologicresearchcenter.com\/efficacy-of-enzalutamide-plus-androgen-deprivation-therapy-in-metastatic-hormone-sensitive-prostate-cancer-by-pattern-of-metastatic-spread-arches-post-hoc-analyses\/","title":{"rendered":"Efficacy of Enzalutamide Plus Androgen Deprivation Therapy In Metastatic Hormone-Sensitive Prostate Cancer By Pattern of Metastatic Spread: ARCHES Post Hoc Analyses"},"content":{"rendered":"
Andrew J. Armstrong, Neal D. Shore, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey Holzbeierlein, Arnauld Villers, Arun Azad, Antonio Alcaraz, Boris Alekseev, Taro Iguchi, Francisco Gomez-Veiga, Brad Rosbrook, Ho-Jin Lee, Gabriel P. Haas, and Arnulf Stenzl<\/p>\n